Bioavailability & bioequivalence studies
A dedicated bioequivalence centre providing clinical and bioanalytical services to pharmaceutical, medical and biotechnology companies internationally. Our clinical pharmacology experts guide your product through the clinical phase and bring the best results to the table for your decision.
- Single-dose, multiple-dose and steady-state studies
- Food-effect and drug-drug interaction (DDI) studies
- Submissions to US FDA, UK MHRA and EMA